Tirzepatide Injection
From $199/month
Dual-action GLP-1 and GIP, dosed weekly. Tirzepatide is the next generation of weight-loss medication, a single weekly injection that activates two gut hormones (GLP-1 and GIP) instead of one.
No insurance required
Licensed US pharmacies
Fast, discreet shipping
Dual-action GLP-1 + GIP in one weekly dose
Greater average weight loss than single-action GLP-1 in trials of the branded medicine, results vary
One weekly injection, personalized and titrated
Get Started
Available only if prescribed by a licensed provider after an online consultation.
Why tirzepatide
Tirzepatide engages both GIP and GLP-1 receptors in vitro.
GLP-1 receptor assay
GIP receptor assay
Dual receptor agonism curves.
Cell lines expressing GIP or GLP-1 receptors show concentration-dependent second-messenger responses to tirzepatide. The schematic plots relative receptor pathway activation from published dual-agonist pharmacology — a molecular characterization, not a patient endpoint.
Source: Coskun et al., “LY3298176, a novel dual GIP and GLP-1 receptor agonist…,” Molecular Metabolism (2018).
Educational research summary only. Schematics illustrate published pharmacology / pharmaceutics concepts and are not clinical results, performance claims, or medical advice.
Related treatments
Ready to get started?
Begin your free online intake. A licensed provider reviews every order, and treatment ships only if prescribed.